Welcome to our dedicated page for Astronova SEC filings (Ticker: ALOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AstroNova, Inc. filings document an operating company with common stock listed on the Nasdaq Global Market under ALOT. Recent reports include 8-K disclosures for quarterly and annual operating results, amendments to its credit agreement, compensation award terms and other material events tied to its Product Identification and Aerospace businesses.
Proxy and shareholder-meeting filings describe board elections, director nominations, executive compensation votes, auditor ratification and governance matters. The filing record also covers capital structure details such as common stock par value, financial obligations under lending arrangements, exhibit disclosures attached to earnings releases and credit agreement amendments, and formal records related to shareholder proposals and annual meeting procedures.
AstroNova, Inc. (ALOT) calls its 2025 Annual Meeting for December 2, 2025 at 9:00 a.m. EST, held virtually. Shareholders of record at the close of business on October 13, 2025 may vote; there were 7,638,423 common shares outstanding on the record date. Previously mailed proxy cards for the earlier meeting will not be counted and new voting instructions are required.
The Board recommends: FOR the election of seven directors; FOR the advisory vote on executive compensation; 1‑YEAR for the frequency of future say‑on‑pay votes; and FOR ratifying the independent auditor. The slate reflects a governance refresh, including Executive Chairman Darius G. Nevin and CEO/director Jorik Ittmann (appointed August 15, 2025), plus independent director Shawn W. Kravetz, added under an August 21, 2025 Cooperation Agreement with Askeladden Capital Management and Samir Patel.
Compensation highlights note a tougher fiscal 2025: Adjusted EBITDA was $12,335,000, below the STIP threshold of $19,000,000, so no fiscal 2025 STIP bonuses were paid to named executives. The company introduced updated fiscal 2026 incentive metrics and granted stock‑settled performance awards tied to multi‑year revenue growth and adjusted EPS, along with time‑based RSUs to key executives.
Padraig Finn, Senior Vice President of AstroNova, Inc. (ALOT), received equity awards on 09/23/2025. The filing shows an acquisition of 600 shares of common stock at a $0 price and 600 restricted stock units (RSUs) that represent the right to 600 additional shares, bringing his total reported beneficial ownership to 1,200 shares. The RSUs vest in two equal annual installments beginning on 09/23/2026.
This Form 4 documents a routine, non-cash equity grant to an officer; it does not report any cash purchase or sale proceeds and was signed by a power of attorney on 09/25/2025.
AstroNova, Inc. (ALOT) reported interim filing details showing financing, segment and expense updates for the periods ended July 31, 2025 and August 3, 2024. The Product ID segment derives approximately 80% of its revenue from recurring supplies, parts and service. Fair-value estimates for acquired intangibles used a 0.75% relief-from-royalty rate and a 15.5% discount rate for trademark valuation. Credit agreements were amended to temporarily increase the revolving facility to $30.0 million until January 31, 2025, and the company borrowed EUR 14.0 million on a Term A-2 loan plus amounts under the revolving facility to fund a purchase. The Term A-2 loan requires quarterly principal payments through April 30, 2027 and a full payment on August 4, 2027. Interest rates on facilities vary by leverage, with EURIBOR-based margins of 1.60%–2.85%; other borrowing includes an equipment loan at 7.06% (monthly payments of $16,296 through Jan 23, 2029) and an MTEX term loan at 6.022% with monthly payments of EUR 17,402 ($18,795) through Dec 21, 2033. The company expects $3.0 million of annualized savings from restructuring actions. For six months, selling and marketing expense declined to $11.3 million (down 8.9%), G&A rose to $10.0 million (up 18.0%) including nonrecurring charges, and R&D was $3.1 million (4.2% of revenue). Equity plan and director compensation amendments and outstanding share counts are described; employees delivered 2,739 shares to cover taxes on vesting at an average market value of $9.01 per share.
AstraNova, Inc. filed a current report to let investors know it has released financial results for its fiscal second quarter ended July 31, 2025. On September 9, 2025, the company issued a press release with these quarterly results, which is included as Exhibit 99.1 to the report and incorporated by reference.
The company notes that the earnings information in this report and in the attached press release is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions and how it may be incorporated into other SEC filings.
AstroNova, Inc. (ALOT) reporting person Padraig Finn received 43,591 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of common stock and is scheduled to vest and settle on 08/15/2028. The reported RSUs show 43,591 shares beneficially owned following the transaction and are held directly. The filing was signed by Daniel Clevenger by power of attorney on 09/08/2025.
AstroNova, Inc. (ALOT) director Richard S. Warzala received a restricted stock award of 3,471 shares on 08/28/2025 under the company's Amended and Restated Non-Employee Director Annual Compensation Program. The award was reported as having a price of $0 (restricted grant), and after the transaction the reporting person beneficially owned 67,866 shares. The Form 4 was signed by power of attorney on 09/02/2025. The filing reflects a routine, compensatory equity grant to a non-employee director and does not disclose cash consideration or derivative transactions.
Yvonne Schlaeppi, a director of AstroNova, Inc. (ALOT), received a restricted stock award of 3,196 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. The shares were granted at a price of $0 and, after the award, the reporting person beneficially owned 44,426.954 shares. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025. The filing documents a routine, non-derivative equity grant to a director as part of standard board compensation.
AstroNova, Inc. (ALOT) director Quain Mitchell I received a restricted stock award of 3,346 shares on 08/28/2025 under the companys Amended and Restated Non-Employee Director Annual Compensation Program. The shares were issued at a price of $0 as restricted compensation. After the grant, the reporting person beneficially owns 101,065 shares directly and 16,701 shares indirectly through a trust where they serve as trustee. The Form 4 was signed by power of attorney on 09/02/2025. The filing documents a routine director equity grant as part of non-employee director pay.
AstroNova, Inc. (ALOT) director Alexis P. Michas received a restricted stock award totaling 3,071 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. After the award, Mr. Michas directly held 21,826 shares. The filing discloses that 535,203 shares are beneficially owned indirectly by Juniper Targeted Opportunity Fund, L.P., for which Mr. Michas is a managing member of the investment manager and may be deemed to beneficially own the fund's holdings; he disclaims ownership except to the extent of his pecuniary interest. The Form 4 was signed by power of attorney on 09/02/2025.
AstroNova, Inc. (ALOT) director Shawn W. Kravetz was granted 2,318 shares of common stock as a restricted stock award under the Amended and Restated Non-Employee Director Annual Compensation Program. The acquisition transaction date is 08/28/2025, reported on a Form 4 filed for one reporting person. The transaction is coded as an acquisition at a price of $0, and the Form shows the reporting person beneficially owned 2,318 shares following the award. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025.